Portal Home For reimbursement information regarding other Centocor Ortho Biotech Inc. products, please click here.
PROCRITline.com Reimbursement Excellence Centocor Ortho Biotech Inc.
Introduction Commercial Payer Prior Authorization Medicare Part D Prior Authorization Please see full Prescribing Information, including Boxed WARNINGS, for PROCRIT® (Epoetin alfa) Medicare Guideline Archives Medicare Guideline Update Table CMS 1450 / UB-04

State Medicare Guidelines / CMS 1500
Select



State Medicare Guidelines / CMS 1500

New Hampshire Printable Version


Summary - Part A  Summary - Part B  

National Coverage Determination

Local Coverage Determinations / Supporting Documentation:
MAC Part A - MAC Part B

CMS 1500 Examples
Initial Claims: Oncology 1 Subsequent Claims: Oncology 2
Nephrology 1 Nephrology 2
AZT/HIV 1 AZT/HIV 2
Surgery 1 Surgery 2
Payers

Part-A
NHIC

Part-B
NHIC

Carrier/FI/MAC Changes




Please refer to the National Coverage Determination (NCD) for additional information that may supercede the Medicare guidelines provided by your local Medicare Carrier, Fiscal Intermediary, or Medicare Administrative Contractor (MAC).



Summary - Part A - Updated August 01, 2010

For additional information on Medicare covered indications for your specific state, please see the appropriate Part A Local Coverage Determinations/Supporting Documentation which may be accessed through the link above or by
clicking here - Part A.

Your state has two Medicare contractors which process claims for Part A providers. If you use WPS (formerly Mutual of Omaha), please select it now. WPS If you do not use WPS, the Medicare guideline summary is below.

Indication ICD-9-CM HCPCS Starting Labs Ending Labs GFR/Serum Creatinine Allowable Dosage Post Chemo
Cancer (chemo) Not Stated J0885
Link
Not Stated Not Stated SC: Not Applicable

GFR: Not Applicable
Not Stated Not Stated
AIDS/AZT 284.89 and 042
Link
J0885
Link
HCT < 34.5% or Hb < 11.5 g/dL, endogenous EPO < 500 mU/mL prior to therapy
Link
Link
Target HCT 30-36% or Hb 10-12 g/dL
Link
SC: Not Applicable

GFR: Not Applicable
Starting dose 150 U/kg 3x/wk
Link
Not Applicable
Renal 285.29 or 285.9 and 585.1, 585.2, 585.3, 585.4, 585.5 or 586
Link
J0885
Link
HCT < 34.5% or Hb < 11.5 g/dL
Link
Target HCT 30-36% or Hb 10-12 g/dL
Link
Date and results of most recent serum creatinine or estimated creatinine clearance, within last month, prior to the initiation of EPO. Values not stated.
Link
Starting dose 150 U/kg 3x/wk
Link
Not Applicable
Surgery (elective, non-cardiac, non-vascular) 281.9, 284.81, 284.89, 285.0, 285.29, 285.8 or 285.9
Link
J0885
Link
HCT < 37.5% or Hb < 12.5 g/dL
Link
Target HCT 39% or Hb 13 g/dL
Link
SC: Not Applicable

GFR: Not Applicable
Not Stated Not Applicable

These summaries have been prepared using the Medicare guidelines. If you would like to receive the Medicare guidelines, you can call PROCRITline® at 1-800-553-3851 or you can contact the Medicare contractor directly at the web address in the State Medicare Payers box above.
R146
Back to Top



Please refer to the National Coverage Determination (NCD) for additional information that may supercede the Medicare guidelines provided by your local Medicare Carrier, Fiscal Intermediary, or Medicare Administrative Contractor (MAC).



Summary - Part B - Updated August 01, 2010

For additional information on Medicare covered indications for your specific state, please see the appropriate Medicare carrier Part B Local Coverage Determinations/Supporting Documentation which may be accessed through the link above or by
clicking here - Part B.

Indication ICD-9-CM HCPCS Starting Labs Ending Labs GFR/Serum Creatinine Allowable Dosage Post Chemo
Cancer (chemo) Not Stated J0885
Link
Not Stated Not Stated SC: Not Applicable

GFR: Not Applicable
Not Stated Not Stated
AIDS/AZT 284.89 and 042
Link
J0885
Link
HCT < 34.5% or Hb < 11.5 g/dL, endogenous EPO < 500 mU/mL prior to therapy
Link
Link
Target HCT 30-36% or Hb 10-12 g/dL
Link
SC: Not Applicable

GFR: Not Applicable
Starting dose 150 U/kg 3x/wk
Link
Not Applicable
Renal 285.29 or 285.9 and 585.1, 585.2, 585.3, 585.4, 585.5 or 586
Link
J0885
Link
HCT < 34.5% or Hb < 11.5 g/dL
Link
Target HCT 30-36% or Hb 10-12 g/dL
Link
Date and results of most recent serum creatinine or estimated creatinine clearance, within last month, prior to the initiation of EPO. Values not stated.
Link
Starting dose 150 U/kg 3x/wk
Link
Not Applicable
Surgery (elective, non-cardiac, non-vascular) 281.9, 284.81, 284.89, 285.0, 285.29, 285.8 or 285.9
Link
J0885
Link
HCT < 37.5% or Hb < 12.5 g/dL
Link
Target HCT 39% or Hb 13 g/dL
Link
SC: Not Applicable

GFR: Not Applicable
Not Stated Not Applicable

These summaries have been prepared using the Medicare guidelines. If you would like to receive the Medicare guidelines, you can call PROCRITline® at 1-800-553-3851 or you can contact the Medicare contractor directly at the web address in the State Medicare Payers box above.
R146
Back to Top